Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

State of Medical Education Research in Anesthesiology: Current Landscape and Future Directions-An Initiative of the Anesthesia Research Council.

Anesthesia and analgesia·2026
Same author

State of Medical Education Research in Anesthesiology: Current Landscape and Future Directions-An Initiative of the Anesthesia Research Council.

Anesthesiology·2026
Same author

Surgical Treatment of Pulmonary Nontuberculous Mycobacterial Infections.

Thoracic surgery clinics·2026
Same author

Comparative outcomes based on pre-Bronchoscopic lung volume reduction (BLVR) Six-minute walk distance (6MWD).

Respiratory medicine·2026
Same author

Reflective ability in medical trainees: reliability and practicality of a measurement instrument and assessment in a large cohort.

Academic medicine : journal of the Association of American Medical Colleges·2026
Same author

Maternal cardiac arrest: a simulation-based review of anesthetic protocols and perimortem cesarean delivery.

Current opinion in anaesthesiology·2026

Related Experiment Video

Updated: May 20, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

Multidrug-resistant pulmonary tuberculosis: surgical challenges.

Michael J Weyant1, John D Mitchell

  • 1Section of General Thoracic Surgery, Division of Cardiothoracic Surgery, Department of Surgery, University of Colorado School of Medicine, 12631 East 17th Avenue, MSC310, Aurora, CO 80045, USA. Michael.Weyant@ucdenver.edu

Thoracic Surgery Clinics
|July 14, 2012
PubMed
Summary

Multidrug-resistant tuberculosis (MDR-TB) poses a global health challenge. While chemotherapy is standard, surgery can be an effective additional treatment for select MDR-TB patients.

Related Experiment Videos

Last Updated: May 20, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Surgical Oncology

Background:

  • Multidrug-resistant tuberculosis (MDR-TB) remains a critical global public health concern.
  • Current MDR-TB treatment primarily relies on chemotherapy, which has limitations.

Purpose of the Study:

  • To outline the global scope of the MDR-TB problem.
  • To review current standard chemotherapy for MDR-TB.
  • To analyze the role and outcomes of surgical intervention as adjunctive therapy for MDR-TB.

Main Methods:

  • Review of the current literature on MDR-TB epidemiology and treatment.
  • Analysis of established chemotherapy regimens for MDR-TB.
  • Evaluation of surgical indications and reported results in MDR-TB management.

Main Results:

  • MDR-TB presents a significant and ongoing worldwide health issue.
  • Chemotherapy is the cornerstone of MDR-TB treatment.
  • Surgery is a viable adjunctive therapy in specific MDR-TB cases, with variable outcomes.

Conclusions:

  • MDR-TB necessitates comprehensive management strategies.
  • Surgical intervention should be considered for select MDR-TB patients as part of a multidisciplinary approach.
  • Further research into optimizing surgical outcomes for MDR-TB is warranted.